• Publications
  • Influence
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.
Rising rates of resistance to antimicrobial drugs among Enterobacteriaceae limit the choice of reliably active forms of these drugs. We evaluated the evidence on fosfomycin as a treatment option forExpand
  • 385
  • 17
  • PDF
Comparison of SCImago journal rank indicator with journal impact factor
The application of currently available sophisticated algorithms of citation analysis allows for the incorporation of the “quality” of citations in the evaluation of scientific journals. We sought toExpand
  • 334
  • 16
  • PDF
Extended-spectrum beta-lactamase-producing organisms.
Extended-spectrum beta-lactamases (ESBLs), which hydrolyse extended-spectrum cephalosporins and are inhibited by clavulanic acid, are spreading among Enterobacteriaceae. The CTX-M enzymes areExpand
  • 316
  • 15
  • PDF
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.
Institutional outbreaks caused by Acinetobacter baumannii strains that have acquired multiple mechanisms of antimicrobial drug resistance constitute a growing public-health problem. Because ofExpand
  • 361
  • 14
Etiology of anemia in patients with advanced heart failure.
OBJECTIVES We prospectively investigated the causes of anemia in patients with advanced congestive heart failure (CHF). BACKGROUND Anemia is common in patients with advanced CHF, and its etiologyExpand
  • 351
  • 13
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
In 7 studies, rates ranged from 26% to 44%; in 2 studies, rates were −3% and −4%, respectively.
  • 296
  • 11
  • PDF
MRSA in Africa: Filling the Global Map of Antimicrobial Resistance
We sought to assess the prevalence of methicillin-resistance among Staphylococcus aureus isolates in Africa. We included articles published in 2005 or later reporting for the prevalence of MRSA amongExpand
  • 113
  • 9
Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.
Enterobacteriaceae that produce serine carbapenemases or metallo-β-lactamases, such as KPC, OXA-48, VIM or NDM, respectively, are spreading mostly as nosocomial pathogens worldwide. Such strains areExpand
  • 133
  • 7
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies.
OBJECTIVES Antimicrobial drug resistance is spreading among Enterobacteriaceae, limiting the utility of traditionally used agents. We sought to systematically review the microbiological activity andExpand
  • 169
  • 7